Bli medlem
Bli medlem

Du är här

2020-08-07

New pan-European research project helps Monsenso enter new markets

Monsenso is partnering with pan-European research consortium in the Go Green Routes project supported by Horizon 2020 programme.

Company announcement no. 7-2020.

Copenhagen, Denmark – 7. August 20120. 

Monsenso is pleased to announce that it is partnering with a pan-European consortium in the Go Green Routes research project supported by the Horizon 2020 programme. The consortium has been granted EUR 10.49 million from the EU to develop innovative solutions that foster mental health and well-being by optimising human-nature interactions for citizens. These innovations will increase the uptake and acceptability of nature-based solutions across the trial cities Burgas, Lahti, Limerick, Tallinn, Umea and Versailles.

Monsenso’s solution will be further developed and used to both encourage green nature-based choices and to monitor citizens’ mental health to help better understand the health impact of nature-based choices for people in cities. Monsenso’s share of the project contribution will be EUR 253.000.

“Participating in a project that combines nature-based solutions, green choices and mental health and well-being is very exciting for Monsenso. A lot of focus and investment is going into green solutions and technologies these years, and this could represent a great potential for us,” says Thomas Lethenborg, CEO of Monsenso. “Moreover, the project will expand our international network and help bring the Monsenso solution into new markets”.

The project will start in September 2020 and run for four years. It is led by University of Limerick and includes 40 partners across Europe among others Mental Health Europe, King's College London, Technical University Munich, Manchester Metropolitan University and universities in Tallinn, Aachen, Torino, Antwerpen, Versailles and Inland Norway as well as the trial cities.

The project will not impact the previously communicated plans and guidance of Monsenso.

This project is funded by the European Union’s Horizon 2020 framework programme under grant agreement No 869764.

For enquiries regarding this announcement, please turn to:

Monsenso:

CEO Thomas Lethenborg
Tel. +45 21 29 88 27
E-mail: lethenborg@monsenso.com 

Certified Adviser:

Norden CEF ApS
John Norden
Tel. +45 20 72 02 00
E-mail: jn@nordencef.dk

Contacts

About Monsenso

Monsenso is an innovative technology company offering  mHealth solution that optimises the treatment of mental disorders. The smartphone-based solution gives  a detailed overview of an individual’s mental health through the collection of outcome, adherence and behavioural data, and it connects individuals, carers and health care providers enabling personalised treatment, remote care and early intervention. Based on continued research and development, our team is committed to developing comprehensive solutions that fit seamlessly into the lives of individuals, increasing the quality and efficacy of their mental health and treatment. Our mission is to help individuals, carers, healthcare providers and researchers overcome the burden of mental illness. To learn more visit www.monsenso.com

Attachments

Författare Monsenso

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.